The DEFB106B gene helps make a small beta defensin protein that supports your body’s early defense against germs on body surfaces. This protein is thought to help control bacteria and support healthy tissue lining, especially in parts of the reproductive tract. If the gene does not work as it should, local protection may be weaker and the balance of microbes in nearby tissues may change.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or to regulate processes in the body. Some genes provide the instructions for proteins, the parts of cells that do the work. Others mainly direct when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and operates, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
DEFB106BGene function
What if the gene works
The DEFB106B gene helps make a small protein in the beta defensin family. This protein supports the body’s first line of defense against germs on body surfaces and linings.
Risk
What if the gene does not work
Changes in the DEFB106B gene may reduce or alter a beta defensin protein that helps cells interact with microbes at body surfaces. Milder and more severe variants can disrupt this activity to different degrees.
Treatment
What does that mean for your treatment
No DEFB106B-specific treatment or drug choice is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the DEFB106B gene.
Gene function
What if the gene works
Your body needs quick protection at surfaces that meet the outside world, such as the skin and lining tissues. The DEFB106B gene helps make a small defense protein that supports first line immune defense at body surfaces. It contributes to everyday protection against microbes and helps local tissues stay balanced.
The DEFB106B gene provides instructions for a small protein used in the body’s built in surface immune response. It belongs to the defensin family, a group of small defense proteins that help protect exposed tissues from everyday germs.
Its protein can act where bacteria and other microbes first make contact with the body. This helps surface tissues stay protected during normal daily exposure to the outside world.
What is a variant?
A genetic variant is a minor alteration in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more strongly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DEFB106B gene can change the peptide’s amino acid sequence or how much of it a cell makes, helping explain how variants influence the DEFB106B gene's function. Milder variants may slightly alter charge, folding, or stability, which can reduce secretion or weaken interactions at the cell surface. More severe variants, including truncating changes or variants affecting key cysteine residues, can disrupt the peptide’s shape more strongly and may greatly reduce or abolish its activity.
How variants are linked to conditions
Variants in the DEFB106B gene do not yet have a broadly confirmed link to a specific health condition, though research on DEFB106B gene variants and health conditions is still developing. Anyone with a reported DEFB106B finding should rely on guidance from their doctor or genetic counselor for personal interpretation.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the DEFB106B gene. People who are concerned about personal or family risk can talk with a doctor or genetic counselor for advice based on their own health history.
Inheritance of DEFB106B variants
There is not yet a broadly confirmed, disease specific Mendelian pattern for the inheritance of the DEFB106B gene variants, and this picture may become clearer as research develops. For families asking about inheritance of the DEFB106B gene variants, the main established point is that the DEFB106B gene is located on chromosome 8, which is an autosome. That means you inherit one copy of the DEFB106B gene from your mother and one copy from your father.
What does my DEFB106B result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for DEFB106B, though this can become clearer as research develops. If you have a specific DEFB106B result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the DEFB106B gene, genetic testing for DEFB106B variants uses a blood or saliva sample. A lab reads the DNA sequence to look for changes in the DEFB106B gene and reports whether a variant was found.
When should I consider getting a genetic test?
There isn't yet a broadly established, DEFB106B-specific clinical reason for testing. Testing decisions are best made with a doctor or genetic counselor, based on your health history, symptoms, and family history.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant involved. Over time, the way the body works is shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work well for one person but less well for another. These differences are common and can influence both how much benefit a medicine gives and how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can shape a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently in different people. For many medicines, genes affect how the body handles a drug or how much effect that drug has. This information can support treatment choices that are better informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the DEFB106B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response. If you have concerns about side effects, a medicine not working as expected, or your family history of health conditions, it is best to discuss them with your doctor.
History
In recent decades, awareness of this gene’s role has grown within the broader study of human defensin genes. DEFB106B entered the scientific literature as researchers mapped clusters of beta defensin genes and recognized that this family is larger and more variable than first thought. Early work focused on identifying related genes across the same chromosome region and sorting out which were distinct genes rather than repeated copies. Building on this early work, scientists refined the naming and cataloging of DEFB106B as genome sequencing improved. Its history is mainly part of the wider effort to understand gene families involved in the body’s first line of defense, rather than a single dramatic discovery or public milestone.